Cadila Pharmaceuticals

30th April, 2021

According to ICMR Former Director General NK Ganguly and Suparno Chakroborti, HOD-Hematology, Dharamshila Narayana Superspeciality Hospital use of immuno-modulator like Sepsivac could prove to be an easy, quick and effective strategy, till herd immunity is reached. ‘In absence of Remdesivir, it can be used as an excellent substitute. Many of our patients have benefited from it.’, stated the Admin Head of a reputed private hospital in Alwar.

downWhiteCurveArrow

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved